Back to top

LACOG 0215 – EVITA

  /    /  LACOG 0215 – EVITA

Prospective evaluation of patients with uterine cervical cancer in Brazilian health institutions

Type of Study: Epidemiological

Sponsor / Support: LACOG, Roche

Primary Objectives: Characterization of uterine cervical cancer in the Brazilian population

Design: Observational, prospective, analytical study.

Sample Size: 800 patients

Principal Investigator: Angélica Nogueira-Rodrigues, Andréia Cristina de Melo, Aknar Freire de Carvalho Calabrich, Fernando Cotait Maluf, Gustavo Werutsky

Countries LATAM: Brazil

Clinicaltrials.gov Identifier: NCT02671071